BriaCell Therapeutics (BCTX) vs Incannex Healthcare (IXHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BriaCell Therapeutics (BCTX) has outperformed Incannex Healthcare (IXHL) over the past year, losing 68.3% versus a loss of 75.8%. Incannex Healthcare is the larger company by market cap ($40.1 million vs $34.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCTX | IXHL |
|---|---|---|
| Share price | $3.92 | $3.20 |
| Market cap | $34.10M | $40.14M |
| 1-day change | -2.00% | +0.63% |
| YTD return | -43.74% | -70.39% |
| 1-year return | -68.33% | -75.80% |
| 5-year return | -95.12% | — |
| EPS (TTM) | $-0.92 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.68 | $14.91 |
| 52-week low | $2.60 | $2.49 |
| Distance from 52-week high | -73.30% | -78.54% |
| Average volume | 280.62K | 98.82K |
| Shares outstanding | 8.70M | 12.54M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BCTX vs IXHL FAQ
Which is bigger, BriaCell Therapeutics or Incannex Healthcare?
Incannex Healthcare (IXHL) is larger, with a market capitalization of $40.14M compared with $34.10M for BriaCell Therapeutics (BCTX).
Which stock has performed better over the past year, BCTX or IXHL?
BCTX returned -68.33% over the past 12 months, compared with -75.80% for IXHL (price return, excluding dividends). Past performance does not predict future results.
Are BriaCell Therapeutics and Incannex Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.